Lv1
50 积分 2024-04-30 加入
Subgroup analysis of elderly patients (≥60 years) with diffuse large B-cell lymphoma in the phase 3 POLARIX study
1个月前
已完结
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
7个月前
已完结
Role of HDL cholesterol in anthracycline-induced subclinical cardiotoxicity: a prospective observational study in patients with diffuse large B-cell lymphoma treated with R-CHOP
9个月前
已完结
Low serum apolipoprotein A1 level predicts poor prognosis of patients with diffuse large B-cell lymphoma in the real world: a retrospective study
9个月前
已完结
A novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse large B-cell lymphoma
9个月前
已完结
Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL
9个月前
已完结
Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high‐grade B‐cell lymphoma (HGBL) and diffuse large B‐cell lymphoma (DLBCL): Can we identify different prognostic subgroups?
10个月前
已完结
Distinct Peripheral T-cell and NK-cell Profiles In HGBL-MYC/BCL2 versus DLBCL NOS Patients
10个月前
已完结
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
10个月前
已完结
Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma
10个月前
已完结
皖公网安备34019202002308
